Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Stroke Collaborators. · 2019
Read Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. by GBD 2016 Stroke Collaborators. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6494974.txt.
Introduction
The GBD 2016 Stroke Collaborators quantify the world's stroke burden across 1990 to 2016 with the Global Burden of Disease machinery of ensemble mortality models and Bayesian meta-regression. In 2016 stroke killed 5.5 million people and cost 116.4 million disability-adjusted life-years, with 13.7 million new cases and 80.1 million survivors living with its effects.
The trend lines split. Age-standardized mortality fell 36.2 percent and the DALY rate fell 34.2 percent over the period, gains in every development quintile, while incidence declined only 8.1 percent. Better survival and treatment, more than prevention, are doing the work, so the absolute burden will stay high as populations age.
Catalog record
| CREATOR | GBD 2016 Stroke Collaborators. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 Published in: The Lancet. Neurology DOI: 10.1016/S1474-4422(19)30034-1 ABSTRACT Summary Background Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, prevalence, deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). DALYs were generated by summing YLLs and YLDs. Cause-specific mortality was estimated using an ensemble modelling process with vital registration and verbal autopsy data as inputs. Non-fatal estimates were generated using Bayesian meta-regression incorporating data from registries, scientific literature, administrative records, and surveys. The Socio-demographic Index (SDI), a summary indicator generated using educational attainment, lagged distributed income, and total fertility rate, was used to group countries into quintiles. Findings In 2016, there were 5·5 million (95% UI 5·3 to 5·7) deaths and 116·4 million (111·4 to 121·4) DALYs due to stroke. The global age-standardised mortality rate decreased by 36·2% (−39·3 to −33·6) from 1990 to 2016, with decreases in all SDI quintiles. Over the same period, the global age-standardised DALY rate declined by 34·2% (−37·2 to −31·5), also with decreases in all SDI quintiles. There were 13·7 million (12·7 to 14·7) new stroke cases in 2016. Global age-standardised incidence declined by 8·1% (−10·7 to −5·5) from 1990 to 2016 and decreased in all SDI quintiles except the middle SDI group. There were 80·1 million (74·1 to 86·3) prevalent cases of stroke globally in 2016; 41·1 million (38·0 to 44·3) in women and 39·0 million (36·1 to 42·1) in men. Interpretation Although age-standardised mortality rates have decreased sharply from 1990 to 2016, the decrease in age-standardised incidence has been less steep, indicating that the burden of stroke is likely to remain high. Planned updates to future GBD iterations include generating separate estimates for subarachnoid haemorrhage and intracerebral haemorrhage, generating estimates of transient ischaemic attack, and including atrial fibrillation as a risk factor. Funding Bill & Melinda Gates Foundation INTRODUCTION Globally, stroke is a leading cause of mortality and disability and there are substantial economic costs for post-stroke care.1 Results from the 2015 iteration of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) showed that although the age-standardised death rates and prevalence of stroke have decreased over time, the overall burden of stroke has remained high.2 As populations age, and low-income and middle-income countries go through the epidemiological transition from infectious to non-communicable diseases as the predominant cause of morbidity, together with concomitant increases in modifiable risk factors, it is expected that the burden of stroke will further increase until effective stroke prevention strategies are more widely implemented.3 Although estimates of disease burden for stroke have been produced by other research groups by meta-analysing data in the literature on incidence and deaths,4, 5, 6 GBD is unique in its approach to generating estimates for all locations, including those with scarce or no epidemiological data, by using all available data from the literature, administrative hospital and medical claims records, and cause of death records. Additionally, the methods used by GBD allow unspecified stroke to contribute to both fatal and non-fatal estimates. These methods allow GBD to document disease burden from stroke in the most comprehensive way over time and to provide the necessary information for priority setting and planning of health services. The results provided here are the most up-to-date estimates of death, prevalence, incidence, and disability for overall stroke and the pathological types of ischaemic and haemorrhagic stroke, using the standard GBD metrics of deaths, prevalence, incidence, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). Research in contextEvidence before this studyThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) produces the only comprehensive estimates of global, regional, and country-specific burden due to stroke from 1990 to 2016. Other sources of population-level estimates include reports from WHO and independent scientific publications of global or regional estimates of deaths or incidence. GBD is the only peer-reviewed, comprehensive assessment of stroke by age, sex, and location that is updated annually. This study quantifies stroke burden in terms of incidence, prevalence, deaths, years lived with disability, years of life lost, and disability-adjusted life-years, updating the estimates previously presented in the GBD 2013 and GBD 2015 studies to include results through 2016. The results presented here are also the source data for the recently published estimates of the lifetime risk of stroke.Added value of this studyThere were several important updates to this iteration of GBD, enabling generation of improved estimates. First, we developed new approaches for our inpatient hospital data processing, which allowed us to include data for several locations that had previously been excluded because of insufficient information about the catchment population. Second, we extended the terminal age group of 80 years and older into 80–84 years, 85–89 years, 90–94 years, and 95 years and older. We updated the previous systematic literature review performed as part of GBD 2013 (search terms “stroke” or “hemorrhagic stroke” combined with “incidence”, “prevalence”, “epidemiology”, or “mortality”) to capture any substantial new sources of data on stroke prevalence, incidence, and mortality. We also performed a literature review to inform the models used to generate severity information (search terms “stroke”, “cerebral infarction”, “cerebral hemorrhage”, or “subarachnoid hemorrhage” combined with “Rankin”). Furthermore, we generated expected values for all measures on the basis of sociodemographic development, allowing us to visualise comparisons between observed GBD results and these expected values.Implications of all the available evidenceThe findings presented in this manuscript provide crucial information that could serve as the basis for resource allocation for stroke prevention, evidence-based planning for acute stroke care, and stroke rehabilitation facilities. Additionally, we provide evidence that most of the burden of stroke can be attributed to modifiable risk factors and identified risk clusters that can be targeted to reduce the incidence of stroke. Because stroke has been identified as one of the priority areas for WHO and the UN in their actions to reduce the burden of non-communicable diseases, global estimates such as those generated by GBD are essential for appropriately targeting such efforts. METHODS Overview Methods used to generate estimates of stroke incidence, mortality, prevalence, YLDs, YLLs, and DALYs have been described in previously; additional details are in the appendix.7, 8 Sources included in all models can be accessed via the GBD 2016 Data Input Sources Tool. For all models, point estimates were calculated from the mean of 1000 draws from the posterior distribution by age, sex, location, and year. 95% uncertainty intervals (UIs) were the 25th and 975th values of the ordered draws. The study was compliant with GATHER guidelines.9 Case definition Stroke was defined according to WHO criteria